Literature DB >> 6541945

Long-term follow-up of central serous chorioretinopathy.

C M Gilbert, S L Owens, P D Smith, S L Fine.   

Abstract

The Wilmer Retinal Vascular Center's experience with central serous chorioretinopathy from 1970 to the end of 1979 was reviewed and compared with previous studies. Retrospective analysis of 73 patients seen at follow-up suggests no clinically significant effect of focal argon laser photocoagulation on final visual acuity or recurrence rate. Patients with initial visual acuity of 20/20 remained at that level, and patients with initial visual acuity of less than 20/30 gained, on average, two to three Snellen lines at follow-up. Approximately one-third of both untreated and treated patients had recurrence or presumed persistence during the follow-up period. With the inclusion of episodes that occurred before the first Wilmer Institute visit about half of each group had recurrence or presumed persistence. Recurrences were most often due to leakage from a site within one disc diameter of the original site of leakage.

Entities:  

Mesh:

Year:  1984        PMID: 6541945      PMCID: PMC1040477          DOI: 10.1136/bjo.68.11.815

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Central angiospastic retinopathy.

Authors:  Y MITSUI; R SAKANASHI
Journal:  Am J Ophthalmol       Date:  1956-01       Impact factor: 5.258

2.  Central serous retinitis. A follow-up study.

Authors:  I Norholm
Journal:  Acta Ophthalmol (Copenh)       Date:  1969

3.  Central serous retinopathy.

Authors:  A Dellaporta
Journal:  Trans Am Ophthalmol Soc       Date:  1976

4.  Long-term follow-up of central serous retinopathy.

Authors:  M Nanjiani
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

5.  Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.

Authors:  D M Robertson; D Ilstrup
Journal:  Am J Ophthalmol       Date:  1983-04       Impact factor: 5.258

6.  Experience with nontreatment of central serous choroidopathy.

Authors:  M L Klein; E M Van Buskirk; E Friedman; E Gragoudas; S Chandra
Journal:  Arch Ophthalmol       Date:  1974-04

7.  Direct and indirect laser photocoagulation of central serous choroidopathy.

Authors:  R C Watzke; T C Burton; R F Woolson
Journal:  Am J Ophthalmol       Date:  1979-11       Impact factor: 5.258

8.  Central serous retinopathy.

Authors:  B R Straatsma; R A Allen; T H Pettit
Journal:  Trans Pac Coast Otoophthalmol Soc Annu Meet       Date:  1966

9.  Argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  P Leaver; C Williams
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

10.  Argon laser treatment of central serous chorioretinopathy.

Authors:  M B Landers; H E Shaw; W B Anderson; A J Sinyai
Journal:  Ann Ophthalmol       Date:  1977-12
View more
  80 in total

1.  Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.

Authors:  Seoung Hyun An; Yoon Hyung Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-09       Impact factor: 3.117

2.  Selective retina therapy in patients with central serous chorioretinopathy.

Authors:  H Elsner; E Pörksen; C Klatt; A Bunse; D Theisen-Kunde; R Brinkmann; R Birngruber; H Laqua; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

4.  Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  R Uetani; Y Ito; K Oiwa; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2012-05       Impact factor: 3.775

5.  Central serous chorioretinopathy: to treat or not to treat?

Authors:  J J De Laey
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

6.  Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors:  Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

7.  Pattern ERG in central serous retinopathy.

Authors:  Jawahar Lal Goyal; Basudeb Ghosh; Vishram Sangit; Sushil Kumar; Parul Jain; Vikas Veerwal; Ritu Arora
Journal:  Doc Ophthalmol       Date:  2014-12-27       Impact factor: 2.379

8.  Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.

Authors:  N K Yadav; C Jayadev; A Mohan; P Vijayan; R Battu; S Dabir; B Shetty; R Shetty
Journal:  Eye (Lond)       Date:  2015-01-23       Impact factor: 3.775

9.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

10.  Improved thickness measurement method for choroidal hyperpermeability in central serous chorioretinopathy.

Authors:  Xing-Wang Chen; Fang-Yuan Han; Gang Su; Le Pan; Shan-Jun Cai
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.